Impact of anti-TNF and anti-IL-12/IL-23 antibody therapy on periodontal inflammation and gingival crevicular fluid IL-6 in patients with inflammatory bowel diseases - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Effects of Anti-TNF and Anti-IL-12/IL-23 Antibody Treatments on Periodontal Inflammation and IL-6 Levels in Gingival Crevicular Fluid Among Inflammatory Bowel Disease Patients

  • By

  • Nicole Neurath

  • Andre Jefremow

  • Selina Sitte

  • Hady Haririan

  • Raja Atreya

  • Marco Kesting

  • June 29, 2026

Share

Original Source(s)

Impact of anti-TNF and anti-IL-12/IL-23 antibody therapy on periodontal inflammation and gingival crevicular fluid IL-6 in patients with inflammatory bowel diseases

  • by Nicole Neurath, Andre Jefremow, Selina Sitte, Hady Haririan, Raja Atreya, Marco Kesting

  • June 29, 2026

Related Content

Editorial: Metabolite-induced metabolic reprogramming in the immune system

Escalating anti-tumour necrosis factor exposure with reductions in surgical resection rates in paediatric inflammatory bowel disease: an 18-year real-world population-based cohort study

Editorial: Biomarkers and beyond: predicting course and tailoring treatment in inflammatory bowel diseases